Security key
492327101
Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)
CUSIP: 492327101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 19,716,217
- Total 13F shares
- 36,741,918
- Share change
- +919,995
- Total reported value
- $581,640,265
- Put/Call ratio
- 104%
- Price per share
- $15.83
- Number of holders
- 159
- Value change
- -$99,583,348
- Number of buys
- 100
- Number of sells
- 70
Report period
Q4 2024
Institutions
159
Top holders
10
KROS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Keros Therapeutics, Inc. SEC filings
Keros Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 492327101
Recent filing periods:
Ownership snapshot
Top shareholders of KROS - Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
ALKEON CAPITAL MANAGEMENT...
13D/G signal
ALKEON CAPITAL MANAGEMENT...
Evidence rows
50
Latest as of
30 Sep 2024
13F
13D/G
Lead comparable stake: 2.7%
13D/G row: ALKEON CAPITAL MANAGEMENT LLC
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ALKEON CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
2.7%
from 13D/G
|
$110,193,690
1,897,601 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
25%
|
$284,492,700
4,899,134 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
13%
|
$152,875,546
2,632,608 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.4%
|
$107,802,193
1,856,418 shares
|
— | 30 Sep 2024 |
| Darwin Global Management, Ltd. |
13F
Company
|
7.7%
|
$88,483,117
1,523,732 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
7.7%
|
$87,948,000
1,514,505 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
5.6%
|
$64,666,171
1,113,590 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
5.2%
|
$59,157,883
1,018,734 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
159
Shares
36,741,918
Rows loaded
159
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
162
Q4 2024 holders
159
Holder diff
-3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend